NEXT Oncology-San Antonio-65273

San Antonio, Texas 78229

0 studies enrolling now · 3 studies all time

What they study most

Neoplasms, Solid Tumors

Studies at this site

• A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer — Running, not enrolling
• A Study to Find a Suitable Dose of BI 1821736 and Test Whether it Helps People With Advanced Cancer — Stopped early
• A Study in Patients With Different Types of Advanced Cancer (Solid Tumors) to Test Different Doses of BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab) and BI 754111 or BI 907828 (Brigimadlin) in Combination With BI 754091 (Ezabenlimab) — Completed